Y MAbs Correlations
YMAB Stock | USD 6.19 0.04 0.65% |
The current 90-days correlation between Y mAbs Therapeutics and Black Diamond Therapeutics is 0.32 (i.e., Weak diversification). The correlation of Y MAbs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Y MAbs Correlation With Market
Modest diversification
The correlation between Y mAbs Therapeutics and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Y mAbs Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
YMAB |
Moving together with YMAB Stock
0.76 | MBIO | Mustang Bio | PairCorr |
0.76 | MBRX | Moleculin Biotech | PairCorr |
0.77 | MGNX | MacroGenics | PairCorr |
0.84 | DNLI | Denali Therapeutics | PairCorr |
0.79 | DNTH | Dianthus Therapeutics | PairCorr |
0.84 | VERA | Vera Therapeutics | PairCorr |
0.78 | DRUG | Bright Minds Biosciences | PairCorr |
0.82 | MLYS | Mineralys Therapeutics, | PairCorr |
0.81 | DTIL | Precision BioSciences | PairCorr |
0.86 | MNKD | MannKind Corp | PairCorr |
Moving against YMAB Stock
0.73 | DMAC | DiaMedica Therapeutics | PairCorr |
0.68 | MESO | Mesoblast | PairCorr |
0.68 | VCEL | Vericel Corp Ord | PairCorr |
0.53 | MDXG | MiMedx Group | PairCorr |
0.48 | MDWD | Mediwound | PairCorr |
0.34 | MCRB | Seres Therapeutics | PairCorr |
0.88 | DRTS | Alpha Tau Medical | PairCorr |
0.77 | MNPR | Monopar Therapeutics | PairCorr |
0.61 | VCYT | Veracyte | PairCorr |
0.53 | MIST | Milestone Pharmaceuticals | PairCorr |
0.51 | SABSW | SAB Biotherapeutics | PairCorr |
0.5 | CDIOW | Cardio Diagnostics | PairCorr |
0.44 | MIRM | Mirum Pharmaceuticals | PairCorr |
0.44 | VCNX | Vaccinex | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between YMAB Stock performing well and Y MAbs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Y MAbs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TCRR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RVMD | 1.83 | (0.48) | 0.00 | (0.50) | 0.00 | 2.27 | 15.16 | |||
BDTX | 3.46 | (0.26) | 0.00 | (0.20) | 0.00 | 5.02 | 25.91 | |||
BCEL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PASG | 7.09 | 0.36 | 0.06 | 0.23 | 7.02 | 20.97 | 84.39 | |||
BLUE | 7.80 | 0.50 | 0.06 | 0.29 | 9.20 | 14.85 | 145.15 | |||
MRSN | 6.61 | (1.51) | 0.00 | (0.38) | 0.00 | 9.24 | 64.16 | |||
ZNTL | 4.57 | (1.28) | 0.00 | (0.82) | 0.00 | 8.00 | 32.39 | |||
TVTX | 2.46 | 0.29 | 0.08 | 3.23 | 2.27 | 5.93 | 20.58 | |||
GBIO | 3.73 | (1.75) | 0.00 | (0.58) | 0.00 | 6.29 | 22.69 |
Y MAbs Corporate Management
MBBS MBA | Senior Officer | Profile | |
Sue Smith | VP Officer | Profile | |
Doug Gentilcore | Senior Unit | Profile | |
FACNP FACP | Chief Officer | Profile | |
Courtney Dugan | Vice Relations | Profile | |
Susan Smith | Senior Officer | Profile |